Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Broncus Medical (02216.HK) Announces Annual Results for 2023 2024-03-28 22:32
Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang 2023-11-24 09:19
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients 2023-09-18 17:36
Broncus Medical (02216.HK) Announces Interim Results for 2023 2023-08-30 23:49
6-Month Registered Clinical Trial Data on World's First Transbronchial Pulmonary Radiofrequency Ablation System for Lung Cancer Announced, Showing Significant Efficacy 2023-08-07 20:41
BRONCUS COMPLETES THE FIRST CASE OF REGISTERED CLINICAL TRIALS OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM 2023-07-10 12:56
Broncus Medical (02216.HK) Announces Annual Results for 2022 2023-03-30 01:05
Broncus (02216.HK) announced interim results 2022-08-31 22:04
BRONCUS COMPLETED SURGERIES ON THE FIRST GROUP OF PATIENTS USING ITS InterVapor®, THE THERMAL VAPOR TREATMENT SYSTEM, AFTER APPROVED FOR MARKETING IN CHINA 2022-07-18 18:11
Broncus Medical (02216.HK) Announces Annual Results for 2021: Operating revenue for 2021 increased 234.2% year-on-year, while product development and commercialization are steadily advancing. 2022-03-30 21:58
INTERVAPOR®, THERMAL VAPOR TREATMENT SYSTEM, APPROVED FOR MARKETING IN CHINA 2022-03-21 17:07
Broncus enter into strategic partnership with New Frontier Health Corporation /United Family Healthcare 2021-12-06 21:44
Broncus Completed the First-in-man Clinical Trial of Its Targeted Lung Denervation Radiofrequency Ablation System 2021-09-30 19:40
Qiming's Portfolio Company Broncus Lists on Main Board of HKEx 2021-09-24 14:10
Broncus Lists on Main Board of HKEx 2021-09-24 11:52
1